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During the COVID-19 pandemic, global health services have faced unprecedented
demands. Many key workers in health and social care have experienced crippling
shortages of personal protective equipment, and clinical engineers in hospitals have
been severely stretched due to insufficient supplies of medical devices and equipment.
Many engineers who normally work in other sectors have been redeployed to address
the crisis, and they have rapidly improvised solutions to some of the challenges that
emerged, using a combination of low-tech and cutting-edge methods. Much publicity
has been given to efforts to design new ventilator systems and the production of
3D-printed face shields, but many other devices and systems have been developed or
explored. This paper presents a description of efforts to reverse engineer or redesign
critical parts, specifically a manifold for an anaesthesia station, a leak port, plasticware
for COVID-19 testing, and a syringe pump lock box. The insights obtained from these
projects were used to develop a product lifecycle management system based on Aras
Innovator, which could with further work be deployed to facilitate future rapid response
manufacturing of bespoke hardware for healthcare. The lessons learned could inform
plans to exploit distributed manufacturing to secure back-up supply chains for future
emergency situations. If applied generally, the concept of distributedmanufacturing could
give rise to “21st century cottage industries” or “nanofactories,” where high-tech goods
are produced locally in small batches.
Keywords: COVID-19, reverse engineering, CAD, 3D printing, product lifecyclemanagement, additive manufacture
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INTRODUCTION
The COVID-19 pandemic caused critical global supply shortages
of equipment and material, ranging from personal protective
equipment (masks, face shields, gloves, aprons, etc) to hardware
such as ventilators (1, 2). The field of medical technology had
been thriving before the pandemic (3) but the pandemic created a
pressing need for extremely rapid innovation and improvisation,
with limited resources, in a high-stakes situation (4).
One hospital in Japan developed a way to turn a refuse bag
into a long-sleeved plastic gown, which could be worn for various
procedures including endoscopies (5). As will be described in
more detail below, 3D printing was used by people around the
globe to make a range of items, from face shields to swabs for
testing (6). A particularly notable example from the early stages
of the first wave of the pandemic in Europe was the development
by Italian company Isinnova of 3D-printed components that
enabled a snorkelling mask to be connected to a ventilator
and used in intensive care units (7). Also in connexion with
respiratory support, a large number of individuals and groups
from various organisations worked on new emergency ventilators
or continuous positive airway pressure (CPAP) systems (8–
10). In some cases, novel methods were used to speed up
the development process, such as parallel testing of alternative
designs (8).
These and other projects emerged as a result of the near-
collapse of conventional supply chains and inability of the
normal manufacturers to meet demand. Many of the efforts
were driven by altruism and a desire to help with the ongoing
crisis. Some of the participants in these projects were hobbyists
with little or no experience in the medical technology field.
Ideas and designs were often shared freely via the Internet,
giving rise to “open source hardware” (11, 12), which was
manufactured in many locations (“distributed manufacturing”).
This distributed manufacturing was built on the enthusiasm of
a broad community of participants who were able to respond
more rapidly than formal organisations. As an aside, it is
important to note distributed manufacturing often involves
production of items very close to the point of use, in contrast
to more conventional factory-based production. It is therefore
possible to speculate that the development of “21st century
cottage industries” or “nanofactories” based on distributed
manufacturing (for various commodities, not just medical
devices and not necessarily open-source hardware) might help
to reduce the carbon footprint of the manufacturing sector,
by reducing the distance over which goods must be moved.
However, this would need to be evaluated on a case-by-case basis
with a full life cycle assessment, taking into account factors such
as material transport requirements, material wastage, energy use
during manufacture, product lifetime and end-of-life disposal. It
is conceivable that additively manufactured components could be
more environmentally damaging than alternatives produced in
the traditional manner.
In some COVID-19 emergency projects, items were designed
from scratch (forward engineering), while in other cases
hardware was reverse-engineered from existing equipment
(13). Sometimes a mixture of the two approaches was used.
Forward engineering refers to the traditional design-build-test-
learn process, where the designer starts with a conceptual
design and finishes with a physical product. In contrast, for
reverse engineering the process begins with a physical product,
and works back toward the detailed design stage. In reverse
engineering, the features and surfaces are captured using a
variety of methods including scanning, to generate an initial
digital representation (14, 15). This initial representation must
then be converted into a usable 3D “as manufactured” model
format by point processing and remodelling, using a range of
algorithms. A design model can be generated to capture design
intent. Finally a CAD file can be used for manufacture of a
duplicate or evolved version of the original product. Reverse
engineering can be used for a range of applications, such as the
replacement of machine parts that are obsolete and unobtainable,
analysing competitors’ products, quality control, reconstructing
designs when the original information has been lost, and so on
(14, 15). Although a number of legal issues may arise with reverse
engineering, the techniques are of interest in various sectors,
including the automotive industry (16) and healthcare, as will
be seen. In some cases, regulators might be able to approve a
reverse-engineered product more rapidly than an unproven de
novo design, on the basis of equivalence between the reverse-
engineered product and the pre-approved original.
The physical-to-digital transition involves capturing the form
and 2D/3D geometry of the target object or assembly of objects.
This can be accomplished a number of non-contact 3D scanning
solutions including laser line (17, 18) scanning, structured light
scanning (19) or CT technologies.
3D scanning captures the surfaces of a component by
projecting light on to the object in the form of a line or pattern
which is captured by the optical sensor, and interpreted using
software and algorithms both embedded within the sensor and
in an external application. 3D point clouds are produced and
stitched together to create a digital representation of the physical
object. Highly reflective or transparent surfaces can be covered
with a non-invasive chalk type spray solution to enable sufficient
light to be reflected without changing the shape of the object.
For some applications optical scanning is insufficient and it is
necessary to use CT (computed tomography) (20), an X-ray based
technique that is also used inmedical imaging. This is particularly
true for highly reflective or transparent parts, if the chalk spray
technique should fail to enable sufficient resolution from optical
scanning. One example of the use of CT scanning in the reverse-
engineering process is provided by the UCL Ventura device, for
which the geometry of pre-existing CPAP devices was verified
using CT scans (10).
If a replica part is required for a given application, a
suitable production technique must be identified. Manufacturing
techniques for consumer goods and medical devices include
injection moulding, vacuum forming, CNC machining, casting
and many others. In the context of the present work, the most
interesting technique for the replication of parts is 3D printing,
a type of additive manufacturing which builds objects layer-
by-layer (21). In forward engineering, 3D printing is often
limited to rapid prototyping prior to scaled-up manufacturing
of the finished product using a conventional manufacturing
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process. As will be presented in this paper, however, when
combined with reverse engineering, 3D printing can act as
a highly adaptable alternative to conventional manufacturing
processes in emergency situations. One 3D printing method is
stereolithography (SLA), which involves use of a laser beam
to solidify the photoreactive printing resin in layers (22). An
alternative 3D printing technique uses a heated nozzle to extrude
and deposit molten polymer layer-by-layer onto a print bed; this
is known as fused deposition modelling (FDM).
Prior to the pandemic, 3D printing was already established
in some sectors of the medical community for applications in
surgery and teaching, and the use of 3D printed parts in surgery
can sometimes reduce the time spent in the operating room
by as much as an hour (23). As noted above, 3D printing was
applied much more broadly during the pandemic (13), from
face shields (24) to nasal swabs for testing (25, 26) and parts
for systems that provide emergency breathing support (6). This
was necessary because the unprecedented demand had exhausted
the conventional supply networks. One study from June 2020
indicated the potential scale of the problem, estimating that, for
some types of hardware, there would be a need for billions of
individual 3D printed items (27).
However, the demand for 3D printed face shields fell off after
a few weeks (based on personal experience of some of the authors
of this paper) as injection moulding was brought online. 3D
printing is better suited for low volume production and injection
moulding offered advantages in terms of cost, time, labour, and
quality control. Effectively, 3D printing was deployed to bridge
the gap between urgent demand and scaled-up production (27).
Normally, technology paradigm shifts tend to occur years apart,
but in this specific case the transition occurred over a few weeks,
accompanied by the partial recovery of the normal supply routes.
The peak in demand for 3D printed hardware and subsequent
fall-off was also seen by a group in Barcelona, who established
an online catalogue of 3D printed items that could be ordered
by local hospitals (28). Ultimately they distributed over 19,000
items, validated with an appropriate ISO standard. For regulatory
reasons, the itemswere limited to those classified as “non-critical”
parts. Nevertheless, it is worthwhile to consider the work done
in this bridging period to better understand what methodologies
can be adopted and adapted in the case of future emergencies.
This is inclusive of all situations where international supply
chains are affected, encompassing emergencies related to public
health, natural disasters or climate change. It is important to note
that 3D printing may also have great potential in places that are
too remote to receive goods shipped from elsewhere and have
insufficient resources to support conventional manufacturing
industries, such as low-income countries. However, there are
practical constraints on what can be successfully 3D-printed,
because the spatial resolution is limited, as are the material
properties of the resins and filament.
The present paper describes several projects related to the
production of bespoke hardware for healthcare applications,
beginning with efforts to reverse engineer and 3D-print two
specific components of medical hardware. The first was a
manifold cover for part of a system that is normally used to
deliver oxygen and anaesthetics to patients. This system can be
used in emergencies as a ventilator, although with some difficulty
(29). The manifold is known to be prone to breakage. A leak
valve and leak port were also considered for reverse engineering
(30), as these are important components of apparatus used in
intensive care of patients with respiratory disease. The leak valve
was deemed unsuitable for this project, but attempts were made
to reverse engineer the leak port. The manifold and leak port
were scanned with optical and/or CT scanning and attempts were
made to produce replicas by SLA 3D printing.
Shortages of critical materials were also expected in diagnostic
testing laboratories and it was therefore decided to investigate the
possibility of reverse-engineering laboratory plasticware needed,
using optical scans of the plates, combs and wells used with the
standard testing protocol.
This paper also describes the development of new forward
engineered designs for a syringe pump lock box used in home-
based palliative care. These lock boxes were designed with a view
to rapid manufacturing from cut plastic components.
Work on the manifold cover, leak valve, plasticware and
syringe pump box provided several insights into the process of
engineering projects for emergency situations. Future projects of
this kind would be greatly facilitated by a streamlined product
lifecycle management (PLM) system (31), which would also
represent a step toward the level of manufacturing accountability
required by various medical device regulations. PLM software
provides a graphical user interface that enables information about
products, activities and people to be stored and managed in an
organised manner, but it is not widely used outside industry. As
the pandemic has seen numerous functions usually performed
by industry shifting to the wider community, it is reasonable to
argue that PLM methods should be made more accessible. The
final section of this paper describes a PLM system developed to
manage creation of bespoke hardware for healthcare applications,
implemented with the Aras Innovator platform [for another
example of the use of Aras see Ref. (32)]. When PLM software is
deployed, documents such as standard operating procedures, logs
and training records can be embedded in the system. Thus, good
document practice can and should be incorporated (33), which
will be a requirement if the bespoke hardware is to be submitted
for regulatory approval. Our own system would require further
testing and development to ensure regulatory compliance.
At the time of writing our hardware and software have
not been deployed clinically. The syringe pump lock boxes
were intended for testing in a local hospital, but the other
hardware has been considered for research purposes only. Any
readers of this paper who wish to make use of our findings
are responsible for ensuring that they act within the applicable




For the purposes of this work, optical scanning was performed
using an EinScan Pro (34). This was operated as follows:
• The scanner and turntable were powered up.
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• The software was opened, and a new project was created.
• A “non-texture scan” was selected and the appropriate save
folder was set.
• The part was placed in the centre of the turntable, fully inside
the ring of white circles, where possible.
• The brightness was adjusted until the first signs of saturation
were seen. Higher brightness was required for darker objects.
• The scan was conducted with the following settings: HDR
= unticked, With Turntable = ticked, Turntable Steps = 16,
Align Mode= Turntable Coded Targets.
• Scans were saved and remodelled using approaches specific to
each part, as described in the Results section.
• For some transparent parts, chalk spray was used [Montana
Chalk Spray Paint Temporary Marking, CH9100 White (35)],
as coating items with particles increases the amount of light
they reflect (36), without contaminating the objects or adding
an offset to the surface.
CT Scanning
CT scanning was conducted using a Mediso Nanoscan
nanoPET/CT scanner (37) (effective resolution ∼35-40
micrometres). Scans were acquired in standard semi-circular
and helical trajectory, helical and with maximum field of view or
medium zoom mode (aiming at achieving better detail). A total
of 480 or 720 projections were collected using 50 kVp, 300ms
and 1:1 binning. Images were reconstructed using filtered-back
projection, Cosine filter at 100% cutoff, medium voxel size and
slice thickness (37 micrometres).
Post-processing and CAD
To supplement the data provided by optical or CT scanning, for
some parts it was also necessary to take manual measurements.
Processing and CAD were carried out using an approach that
differed depending on which part was being examined, with the
software tools SolidWorks, SolidEdge and Autodesk (references
given in relevant section).
3D Printing
The manifold cover replacement and leak port prototype were
produced using a Formlabs Form 2 3D printer (38). A standard
clear FormLabs resin was used (39). Following printing, parts
were sanded where necessary to remove any sharp edges left
after removal of scaffold material and cleaned in IPA to remove
residual print resin to prevent further curing that might affect the
part shape.
CASE STUDIES
Manifold Cover for Anaesthesia Machine
The first case study was the manifold cover of an adjustable
pressure limiting (APL) valve circuit from a GE Healthcare Aisys
Carestation (Figures 1A–D) (40). Typically, this equipment
would be used to deliver oxygen and anaesthetic agents to
a patient; however, during the first COVID-19 peak, such
anaesthesia machines were utilised as ventilators. At that time,
the NHS Lothian Medical Physics team (Edinburgh, UK)
identified the manifold cover as being one of the components
FIGURE 1 | (A–C) Different views of the manifold for the Carestation. (D) The
position into which the manifold fits in the Carestation. (E) Depiction of the part
in the scanner. (F) The Einscan Pro setup used to scan the part. (G) The
surface mesh after manual adjustments/corrections.
with an increased risk of damage. It was also noted that the shape
of the manifold cover was moderately complex and contained a
range of design features common to other parts, including curved
edges and surfaces that needed to provide a seal. As such, it was
selected as a suitable candidate to assess the feasibility of the
reverse engineering process.
The part was scanned using the Einscan Pro setup with
controlled light (Figures 1E,F) and resulting images were
manually corrected to obtain the surface mesh shown in
Figure 1G. 3D modelling of the part relied heavily on the
use of this surface mesh; however, the scan was unable to
accurately capture all of the original part details, with the missing
information mostly concentrated in the narrow grooves of the
manifold port and around the outer sealing surface as marked in
Figure 2. The holes in the mesh were caused by the shadowing
of these regions. Relatively higher features in the surrounding
areas prevented the 3D scanner from accurately capturing the
surface topology of the part. This limitation of the 3D scanning
process made the modelling more intricate. Hence, to correct
the mesh and overcome this problem, mesh post-processing was
carried out using Autodesk MeshMixer (41). All information
synthesised from the available mesh files was merged into a
single representation, capturing features and 3D geometry to
create design intent. This required manual repair of the holes
within the mesh and removal of extraneous parts. The mesh was
then aligned with the world coordinate system, smoothened and
optimised for use in a CAD system.
Following the post-processing, the corrected surface mesh was
employed as a reference geometry for constructing a parametric
CADmodel using SolidWorks (42). As the 3D scan data captured
only the surface geometry but did not contain any dimensional
information, the 3Dmesh was calibrated and scaled to accurately
represent the manifold cover. This involved measurement of
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FIGURE 2 | Surface mesh obtained by 3D scanning. The pink-shaded areas (bounded by the blue contours) represent the missing information. The scanner was
unable to collect this information due to shadowing [(A) top and (B) bottom views].
physical dimensions of the part. The bag port diameter and
the distances between the manifold cover fixture holes were
measured using Vernier callipers. These dimensions were used
as the reference values to scale the rest of the mesh. Using
the automatic feature recognition functions available within the
software package, the reference planes and points were acquired.
The semi-manual part creation with a direct mesh referencing
approach was chosen as it was found to be more accurate than
solely relying on the automated geometry recognition tools. In
order to define the solid part features that overlay the mesh body,
a series of 2D curves were captured by slicing the mesh and
obtaining the cross-sections at a range of heights. These formed
the reference contours of the solid part features.
As the turnaround time was an important factor in the
process, the manifold cover geometry was partially simplified.
The aimwas to accurately reproduce only the design features with
the critical dimensions such as the sealing surfaces, fixture points
and connexion ports. Therefore, the breathing circuit assembly
was analysed to evaluate the features of significance. The areas
shown in Figure 3, namely, the bag port, manifold port, outer
sealing surface and the position of the screw holes, were identified
as the key features for the manifold cover to work as a functional
replacement part.
Following the parametric CADmodelling, the manifold cover
replacement was produced using a FormLabs Form 2 3D printer
(38). The SLA method was selected to ensure high 3D print
quality, dimensional accuracy and highly isotropic properties.
FDM would not have been appropriate as the structures
would have been of low quality, with lower strength and poor
surface finish.
The original manifold cover was made of polyphenylsulfone,
a material of relatively high mechanical strength, good heat
resistance and excellent resistance to acids, bases, oxidising
agents and most solvents, making it well-suited for many medical
applications. With this in mind, a standard clear resin (39)
was used for the initial prototyping stage described in this
paper. Resin options with higher toughness, thermal or chemical
stability (e.g., FormLabs Rigid Resin, Formlabs Tough Resin)
could be more suitable for further design iterations.
The manifold cover was positioned on the build platform so
that the required support structures were only attached to the
non-functional regions of the part (Figure 4). The printer layer
height was set to 0.05mm and the printing process took 10 h
to finish.
During the post-processing of the printed part, the support
structures were removed, the part was rinsed in isopropyl alcohol
(IPA) and the remaining uncured resin was washed off. No
post-curing treatment was applied.
The evaluation of the first prototype (Figure 5A) revealed that
the 3D printed part did not fit the breathing circuit assembly. Key
features, namely the diameters of the bag port and the manifold
port, were 0.08 and 1.07mm larger, respectively. The bag port
feature was adjusted in the CAD model to compensate for the
3D printing inaccuracies; however, the manifold port was larger
due to a design oversight – the O-ring groove on this feature
was not identical to the original part. The main reasons for this
design inaccuracy were traced to the lack of reliable mesh data,
mesh holes in the manifold port region (Figure 2), and absence
of physical measurements. To modify the design, a set of physical
measurements was taken by the NHS staff on-site.
The second iteration (Figure 5B) of the design showed that
the applied changes were suitable and the 3D printed manifold
cover fit the assembly. Despite this, a different problem was
discovered subsequently – the seal was imperfect and gas leakage
occurred. Similar to the first design iteration, the outer surface
geometry was solely based on the mesh data and was not
reproduced to the required accuracy.
Before the third iteration of the design was completed, the
project was stopped as the demand for such systems decreased
at the end of the first COVID-19 wave. The experience also
suggested that the chosen methods were not ideally suited to
this particular part, and without the know-how of the original
manufacturer it would be practically impossible to guarantee
long-term satisfactory performance of the part. Furthermore,
the legal and regulatory situation presented insurmountable
challenges, and it was not clear whether the part could have
been used even if its performance had been appropriately
validated. The project is still highly instructive, as it reveals
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FIGURE 3 | Key functional design features of the manifold cover marked in red [(A) top and (B) bottom views].
FIGURE 4 | 3D printing preview: the manifold cover in blue and the support structures in grey [(A) front and (B) back views].
FIGURE 5 | Photograph of (A) the first and (B) the second manifold cover prototypes made using 3D printing. The letters NFCU stand for Not For Clinical Use.
the strengths and limitations of the processes used, and
some of the methods could be applied more successfully to
other parts.
Due to the remote working arrangements caused by the
COVID-19 pandemic, the design process was highly challenging.
The manifold cover had to be designed by an individual who
did not have physical access to the original part. Therefore,
the design heavily relied on the 3D scan data while a few
design decisions were based on the information provided in
the technical reference maintenance manual (40). The physical
measurements of the original part remain a crucial aspect of
any reverse engineering process as the data collected using 3D
scanning approaches often suffer from shadowing and mesh
distortion. Accurate reference measurements are vital during
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FIGURE 6 | Schematic of non-invasive ventilation system. Black arrows
represent air going to the patient, and red arrows are exhaled gas. Also shown
is a photograph of the original ResMed leak port.
the mesh editing stage and can highly reduce the number of
design iterations.
Leak Valve and Leak Port
During the COVID-19 pandemic, ventilation was used
extensively as a treatment for severe respiratory symptoms.
Non-invasive ventilation (NIV) involves the provision of air
via a mask and is commonly used for treatment of COVID
patients (43). In this project, components of NIV systems were
considered as candidates for reverse engineering, as many
hospitals were experiencing supply shortages. Two specific
components were considered, both originally supplied by the
manufacturer ResMed: a leak valve and a leak port. The former
contains an anti-asphyxia valve, which is designed to protect the
patient if the air supply fails. Leak valves were in short supply
during the pandemic, and ResMed released guidance on the use
of the leak port in place of the leak valve in emergency situations
(44), noting the inherent risks. The leak valve/port was to be
installed in the air line between the ventilator and the patient
(Figure 6). As a result of the aforementioned supply shortages,
NHS staff anticipated a potential need for a back-up option
should both parts become unavailable. The reverse engineering
and production of leak valves and leak ports was therefore
chosen as the second case study for this project.
Initially, optical scans of the original parts were obtained using
the Einscan Pro system; however, due to the transparency of the
parts the image quality was too poor to use. To overcome this, the
parts were coated in a chalk spray. The part was scanned again,
and the scan was processed using Einscan software that allowed a
point cloud to be converted to a 3Dmodel, before being exported
in STL format. Although the chalk spray made the part opaque
enough to scan using the Einscan Pro system, it was only able
to capture the larger features of the part. As a result the leak port
was then scanned using aMediso Nanoscan CT scanner (effective
resolution 35–40µm). Scans were acquired in standard, helical
and medium zoom mode.
During the initial evaluation of the scanned parts, it was
determined that the leak valve would be too complex to reverse
engineer and produce using the techniques available at the time.
This was due to it being made of multiple components and
FIGURE 7 | CT scan of the leak port. Due to limitations of the scanning
equipment, the resolution of the slot features was poor.
FIGURE 8 | (A) Final CAD model of the leak port; (B) Pre-processing of leak
port, with support structures; (C) Printed leak port.
materials, i.e., it incorporated an anti-asphyxiation valve. As such,
the remainder of this case study focused solely on replicating the
leak port.
CT scans were processed using 3D Slicer software (45),
this allowed images to be segmented, and converted to a 3D
model, for export as an STL file. The optical and CT models
were imported into Solid Edge (46), where reverse engineering
techniques (similar to those described in the previous section)
were employed to fit surfaces to the STL that allowed measuring
of the features and for a new 3D model to be produced for
printing. Although larger symmetrical features were readily
duplicated, the main challenge was matching the slot features on
the front of the port. These slots were very small, and, as the
parts were scanned using medical grade CT, the resolution was
relatively low compared to industrial standards (Figure 7). This
meant that the edges appeared jagged and could not be easily
copied from the scans. As an alternative, Vernier callipers were
used for additional measurements.
The leak port consisted of a series of symmetrical features,
but it was not possible to determine their dimensional tolerances
for manufacture. When these features were measured during the
CAD phase it became apparent that they need to be accounted
for in the final model. As a result, measurements were taken
from multiple areas, and averages taken. An assumption was
made that the design intent was for these features to be as
symmetrical as possible, with the measured bounds assumed
to provide a maximum and minimum allowable deviation. The
final model (Figure 8A) was made transparent and overlaid
with the original scan file to identify regions that may have
large deviation.
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The final part was printed using the same FormLabs Form
2 printer as described in the previous section, with a print
time of about 5.5 h. Due to the overhanging features on the
part, additional lattice supports were applied in pre-processing,
as seen in Figure 8B. These were removed and sanded down
after printing was finished. The final part was printed using the
same clear resin described in the previous section, and is shown
in Figure 8C. Following printing parts were cleaned in IPA to
remove residual print resin. Before real use, parts would need to
undergo sterilisation to ensure parts are clean and any unwanted
particles, chemicals or bacteria have been removed.
When evaluating the replicated leak port, it was important
to discuss a number of key points that were identified during
the reverse engineering process in regard to efficacy and patient
safety. Although the final model matched the scanned data well,
only one port was available at the time for assessment. As a result,
there was a reduced data set with regard to measurements, which
had the potential to effect the accuracy of the replicated part,
and possibly effect how well it interfaces with the ventilation
system, and/or how well it functions for its intended purpose.
Furthermore, as with the manifold cover, there was also the
possibility that issues with accuracy could be exacerbated by
distortions during scanning andmanufacturing, and/or incorrect
assumptions made during the design phase. Therefore, validation
that the part fits and functions as required would be necessary
before the part could be used. It would also be essential to
evaluate the best material for replicating parts. As mentioned in
the previous section, there were a few medical grade polymers
were considered for resin printing; however there was insufficient
scope in the project to explore this further. For future work,
the selected material must be biocompatible, strong enough and
capable of being sterilised before use without detrimental changes
to the final part.
It is interesting to speculate about alternative methods for
addressing a shortage of leak ports. It may be possible to
use components intended for other purposes, with or without
modification. For example, there may be connectors of similar
dimensions but lacking slits, which could bemodified by addition
of the necessary holes. This process would need to be carried out
carefully to avoid splitting the connector.
Plasticware for COVID-19 Testing
At the outset of the pandemic, it became apparent that there
would be the need for widespread diagnostic testing. Such tests
were developed rapidly, with both commercial and more cost-
effective solutions now widely available (47, 48). The standard
and most sensitive test is based on the detection of ribonucleic
acid (RNA) from SARS-CoV-2, the coronavirus that causes
COVID-19, using reverse transcription quantitative polymerase
chain reaction (RT-qPCR). The first step in this process is the
isolation of RNA from patient samples, the efficiency of which
is greatly improved by the use of automation. One widely
used procedure in the UK (49) employs the KingFisherTM lab
automation platform [developed by Thermofisher ScientificTM
(50)]. The KingFisherTM system uses 96-well plates with a
corresponding tip comb, both made from polypropylene. To
prevent contamination between samples and ensure accurate
test results, new plates for both sample wells and tip combs are
used for each run. This requirement, combined with the rapidly
increased demand of RT-qPCR testing, and reduced capacity of
production and delivery due to lockdown, led to concerns that
shortages in plasticware could hinder mass scale testing (51).
In the laboratory, liquid samples are placed in deep wells in
a 96-well plate. The corresponding tip comb is attached to a
movable head within the KingFisherTM system. The tip comb is
lowered into the 96-well plate to add or remove particles from the
samples. Magnetic rods within the KingFisher head are inserted
into the tip comb when there is a need to attract magnetic beads
to the tips (The manufacturer supplies a video: https://www.
youtube.com/watch?v=cace7rRTIww).
If the original manufacturer was unable to meet the
demand for plasticware, it was hypothesised that production of
KingFisherTM compatible plates could be outsourced to other
institutions, such as universities, or other industrial producers
of plastic products (including for instance manufacturers
of disposable cutlery and similar items). The designs were
proprietary, and it was uncertain if permission would be granted
to begin 3rd party production should the need have arisen. As
the pace of the pandemic increased, it was decided that, as a
3rd case study within this project, 3D designs of the existing
plates/combs should be prepared in the event that reverse-
engineered plasticware would be needed at short notice and legal
clearance would be given for their use. It was also unclear what
legal clearance would be needed, as it appears that the KingFisher
system was originally covered under US patent 6448092 (52),
which expired in 2015, but there may be other applicable patents
that are still in force.
In contrast to parts such as the leak port, in this case
the shape of the plates and combs is absolutely critical to
their function and faithful reproduction would be required
to ensure compatibility. Optical scanning with a chalk spray
was attempted for the laboratory plasticware, but the quality
of the scans was insufficient. CT scans of the deep well, tip
comb and holder plastic plates were performed using a Mediso
nanoPET/CT scanner, as described above. These scans generated
3D models of each plate, but they did not cover the entirety
of each plate. There were gaps in the model, and as the plate
was thin the plastic was prone to bending. This meant that the
CT scans were not suitable for direct replication, but, instead,
were used as references to model the plates in combination with
manual measurements.
To test this approach, the tip comb plate was focused on as an
example. Autodesk Inventor (53) was used to generate sketches
of the CT scans that would allow for dimensions to be measured,
such as the diameters of holes, the thicknesses of walls, and
the grid spacing for a 96-well configuration (Figure 9A). These
sketches accommodated measurements of the complex structure,
which would otherwise be difficult with manual measurements.
It also helped to account for variances in dimensions produced
by the CT scanner and curvature of the original plastic part.
Measurements were taken at multiple points and averaged to
account for variances in the CT scan. Measurements were
also cross-referenced against manual measurements taken with
Vernier callipers (Figure 9B).
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FIGURE 9 | (A) Autodesk Inventor model (wireframe with hidden edges) of a CT scanned 3D model of part of a KingfisherTM comb plate. The model was split into
distinct parts to allow for the measurement of its dimensions; (B) Manual measurements of the original KingfisherTM comb plate using Vernier callipers. (C) Final 3D
model of reverse engineered KingfisherTM compatible plate, which was rendered using Blender.
To simplify the production of a 3D structure, the design was
split into 2 parts: the base plate; and the teeth of the combs. The
base plate was a simple flat plate that featured holes in a 96-well
grid configuration, and 4 raised fittings on the outer edge that
allow for mounting in the Kingfisher system. The individual teeth
were split into 4 parts (dubbed “stub,” “barrel,” “bulb” and “tip”)
to measure the changing diameter of the inside of the tip at each
stage and allow the varying angle of the outside of the combs
to be recreated as closely as possible. Once a tooth design was
produced, it was duplicated and aligned with the 96 holes on the
base plate and the two parts were merged to produce one final 3D
file (Figure 9C) using Blender (54).
The dimensions of the inner, hollow sections of each comb
were of particular importance, as magnetic rods will be moved
in and out automatically by the Kingfisher system machinery. If
the inner chamber were too narrow or too short, this could result
in damage to the machine or malfunction during operation. It
was also important to maintain the thickness of the walls. As
the magnetic rods within the comb are used to attract magnetic
beads in solution, increasing the thickness of the walls could have
reduced the efficacy of the process, affecting the performance of
the testing protocol. If the walls were too thin, the part could have
been too weak. In this case, the part might have been vulnerable
to breakage during operation, potentially contaminating the
magnetic rods. The slope of protruding features would be
important not only to ensure that all the parts fitted together as
required, but to ensure effective removal from a mould during
mass production.
Fortunately, these designs were never needed. It is important
to note that for mass production, 3D printing would not be
suitable due to the long print times needed to produce a
single plate (at least several hours per plate). Nevertheless,
with a variety of temperature and force resistant resins and
filaments available, 3D printing could potentially be used to
rapid prototype mould tools for conventional manufacturing
processes which are better suited to mass production e.g.,
injection moulding or vacuum forming (55, 56). Factors such as
sterility and potential contamination from pyrogens, RNases, and
DNases would still need to be addressed. As 3D printing was
not a suitable technique for mass production, prototypes were
not tested, but the design is believed to be sufficiently accurate
for use.
While the design work was being carried out, some laboratory
tests were performed that suggested plasticware could be cleaned
and re-used. While this is contrary to standard molecular biology
practice, it is worth noting that this procedure could be adopted
in case of future shortages. This approach would potentially
be superior to the use of reverse-engineered plasticware, and
would also be more sustainable, leading to generation of
less plastic waste. Other solutions could potentially be found,
further discussion of which is beyond the scope of the
present work.
Syringe Pump Lock Box
During the pandemic, much attention was focused on ventilators
and related systems, but there has been a massive impact on
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all aspects of health and social care, changing the way in
which healthcare is delivered. For example, as the COVID-
19 pandemic placed more pressure on hospitals, more patients
were expected to undergo palliative care at home. This often
involves the administration of controlled painkillers via syringe
pump drivers, which administer medication such as morphine
subcutaneously in a continuous manner over an extended period
(57) (Figures 10A–C). To prevent tampering with the syringe
pump during operation (for instance by carers), the syringe pump
is secured within a lockbox (Figure 10D). These lock boxes are
prone to breakage, particularly around the moving parts (hinge
and locking mechanism). A potential shortage was identified due
to increased demand and potential lack of availability from the
supplier, BD Healthcare. It was therefore decided to investigate
the feasibility of producing an alternative syringe pump lock box.
The new lock box was required to hold the pump securely,
with cut-outs to enable access to the display, control panel, and
battery access panel. An opening was required for the drug
delivery line attached to the syringe. The lock box would need
to be robust and resistant to damage if dropped. The lockbox
was required to house a pump carrying a syringe as large as
50mL. Cleaning of the box would typically be performed with
detergent wipes. As the box would need to be produced quickly
in a workshop (such as that in a university) at low cost and a
small number of units would be required, it was to be made from
laser-cut plastic components rather than by injection moulding
or other similar method. The new box was to be compatible
with the barrel locks of the original boxes, because the locks are
less susceptible to breakage than the box itself. A new box was
designed tomeet this specification (Figure 11), with a 3D-printed
lock mechanism to incorporate the original barrel within the new
design. As the T34 syringe pump is designed to be portable, the
lockbox does not need design features that would allow it to be
secured to a solid fixture.
Prototypes of the new box were made from 3mm thick
Extruded Acrylic. The laser cutter used was an HPC 150W CO2
laser cutter (58), The settings used were 100% power at 12
m/min. The lock spindle, designed to fit existing supplied lock
barrels, was 3D Printed in ABS on a Fortus 250 mc printer (59).
The plastic sheet parts were cleaned with IPA before assembly.
Interlocking panels were bonded together using adhesive Tensol
12 (60).
The new lock box is designed to hold the pump securely,
preventing lateral motion. In clinical use, the box is often
subjected to impacts, for example when falling from a patient’s
bed to the floor. Consequently, protective edging is required.
A medical grade polymer edging strip silicone L section PC60,
supplied by Advanced Materials Ltd (61) was tested, but the
finish was found to be unsatisfactory and a 3D-printed frame
was produced instead. The new box is believed to be suitable for
clinical use but at the time of writing it has not been deployed.
PLM
The experience gathered from engineering the manifold,
leak port, plasticware and lock box was used to produce
a detailed Product Lifecycle Management (PLM) tool with
appropriate workflows to coordinate the production of bespoke
medical equipment. This tool was implemented using Aras
Innovator – a software platform for complete, end-to-end
PLM. Aras had the capability to cover various elements of
PLM, including requirements, engineering, manufacturing, and
operation. During this project, PLM tools, such as the one
shown in Figure 12, led to the production of good practice
documents reporting on decisions and allowing for validation
and traceability. The PLM workflows refer to the “University
of Edinburgh,” but this is a placeholder for any engineering
organisation that could be helping to provide emergency
manufacturing support to a local hospital.
The workflow, shown in Figure 12, was separated into clear
product life stages, which could be validated by the production
of signed technical documents that provided process clarity and
traceability. These stages included:
1. Data Gathering
• Definition and technical specifications of the part by NHS
staff (i.e., documents, pictures, recorded meeting with the
CAD designer).
• Where required: part scanning using appropriate imaging
modalities (e.g., optical scanning with/without chalk spray, CT
scanning and image refinement/correction).
• Production of a user requirement specification
(URS) document.
• If situation permits, designer should observe the situation in
which the part is to be used or be provided with alternative
option such as a video.
2. Specifications Definition
• Meeting organised by the technical production team and the
coordinator to assess the gathered information and to define a
production strategy.
• Production of a technical specifications fill in form (designated
by the abbreviation FRM; there would need to be a form for
each key step, as indicated here).
3. Computer-Aided-Design (CAD)
• Production of designs.
• Comparison with the part scans (where applicable) and
assessment by production technician.
• Production of a CAD validation fill in form (FRM).
4. 3D Printing and Ex Situ Validation
• Production of part (by e.g., 3D printing) using the validated
CAD design, SOPs and the technical specifications fill in
form FRM.
• Where applicable: comparison of the original part and its
replicate – using both manual measurement and additional
imaging (optical or CT scanning).
• (Contingent on achieving acceptable part quality for in-situ
validation) Sterilisation and packaging as defined by the
technical specification fill in form.
• Production of a 3D printing fill in form (FRM) or equivalent
for other production technique
5. In situ validation
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FIGURE 10 | Syringe pump and original lockbox. (A) Schematic diagram showing syringe pump with syringe, enclosed in lock-box. (B) Optical scan of pump, to
assist with dimensioning of new box. Photographs of syringe pump (C) and existing lock-box (D), various angles.
• Confirmation of legal approval prior to any assessment/use.
• Delivery of part and in-situ assessment by the NHS Medical
Physics team.
• Meeting organised with CAD designer to discuss the
results of the in-situ assessment and identify any further
design iterations.
• Decision made on part redesign or initiation of production.
6. Production
• Confirmation and approval of final technical specifications.
• Creation of a production SOP.
• Initiation, and subsequent continuation, of production and
delivery process to reach final production numbers.
A blank user requirement specification document, SOP and fill-in
form are provided in the Supplementary Information, together
with a “coordinator’s manual.” Additional documents would be
required to record some aspects of the project such as the training
of personnel.
For each new part to be produced, five roles within the PLM
had to be assigned:
1. A part production coordinator
2. An NHS Medical Physics contact person
3. A CAD designer
4. A 3D printer and material contact
5. A delivery contact
Importantly, these roles were part-specific so individual roles
could change between production pipelines for different parts.
Also, the coordinator had the option to replace anybody in
the pipeline if required. This would be crucial for emergency
production pipelines where individuals might have had multiple
external constraints leading to an important turnover, or
simply in case someone needed to be replaced (e.g., one
individual getting COVID-19). The PLM workflow facilitates
tight collaboration between clinical staff and designers, with
an iterative process that can enable a rapid turnaround if
fully implemented.
The Aras Innovator software (see Figure 13) facilitated
all these steps by providing a visual interface, PLM
overview, reminders for personnel on required actions, good
practice documents, and project history. The implemented
PLM tool included up-to-date template documents for
validating each step while it recorded all changes for future
reference. For loop processes involving several iterations,
a versioning system for good practice documents was
integrated to the software. In the event of going to full
production, these various features would have been crucial
for achieving part certification, as every step (design, printing,
assessment) would have needed validation and reporting in
appropriate documents.
Although full production did not occur within the lifespan
of this project, and further development would be needed
to ensure regulatory compliance (in line with applicable ISO
standards on medical devices, testing and quality management
systems), the PLM tool developed here could act as a
valuable starting point for creation of a tool to be used in
future emergency scenarios where the movement of people
and supplies are restricted, and distributed manufacturing
becomes a crucial alternative. Importantly, PLM tools such
as Aras enable users to make many modifications and adjust
the pipeline for alternative workflows (for example, using
techniques other than 3D printing). Clearly defined work
packages and documented product life stages are key in order
to achieve robustness and fluidity of the workflow while
ensuring accountability. Software platforms other than Aras
could be used and lessons learned here would be transferable to
other systems.
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FIGURE 11 | (A) New design of lock box, made using laser-cut plastic parts. Units: mm. (B) Assembly of the lock box. (C) The parts to be laser-cut from the plastic
sheet. Units: mm. (D) The assembled prototype (without edging).
CRITICAL EVALUATION OF PROTOTYPES
As discussed above, the second version of the reverse-engineered
manifold cover could be installed in the Carestation but was not
fit for purpose due to a leak in the system (Figure 14). In the case
of the leak port, the approaches adopted did enable the physical
form of the part to be replicated with reasonable accuracy, but the
function of the part could potentially have been reproduced by a
part with shape differences. In contrast, accurate reproduction of
the shape of the tip combwould be essential to ensure appropriate
function, and the design was believed to be sufficiently accurate
for use (Figure 14). It was not tested as 3D printing would not
be suitable and more appropriate manufacturing methods were
not available.
The lock box was the most successful of the four hardware
projects. Based on feedback from the hospital team, it is
believed to be suitable for use, subject to appropriate approvals
and very minor design modifications (Figure 14). The lock
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FIGURE 12 | Schematic diagram of the Aras PLM tool for the production of bespoke medical equipment. The first row highlights the product life stages. The second
row identifies the personnel roles at each stage. The third row shows the workflow of tasks and activities. The roles associated with each task or activity are identified
by the corresponding numbers (top right corner of each task box) e.g., the first task in the “data gathering” stage has numbers 1 and 2, meaning it involves NHS
Medical Physics personnel, and personnel working at the interface between the NHS and the engineering organisation. The fourth row outlines the data output.
box was designed by forward engineering rather than reverse
engineering. In many respects, its design was less constrained
than that of the other components. Its performance was also
easier to assess, as defects would be more readily apparent. The
manufacturing method chosen would be suited only to low-
volume production, as with the manifold cover and leak port.
The lock box represents an example of forward engineering a
new solution rather than reverse engineering. Other alternatives
to reverse engineering include re-using old parts (reconditioned
if required) and identifying other components that could be
modified to perform a similar task. Re-use was noted as a viable
approach for addressing plasticware shortages, and the possibility
of re-purposing other components was noted in the context of the
leak port. Themanifold cover is probably themost problematic of
the parts examined here, as re-use is unlikely to be an option if the
part is broken, the part is so specialised that other components
could not replace it, and reverse engineering has limitations, as
has been shown.
CONCLUSIONS
Due to the evolution of circumstances, the design process for
some of the items was not completed. Our project was driven by
real-world needs, and as the situation changed, the demand for
parts such as the manifold, leak port and improvised plasticware
faded. Consequently, decisions were not taken on aspects such as
the final material choice, the sterilisation procedure and the final
form of the designs. However, there are numerous insights that
can be extracted.
Most of the activities covered were performed in the early
stages of the pandemic, during lockdown, when COVID-safe
working practice were very new. This presented some difficulties
in terms of the movement of parts and personnel. For instance,
in the case of the manifold, the CAD work was carried out by
an individual who had never had access to the actual part itself.
This experience underlined the importance of the data gathering
and specification stages of the development pipeline, and this
was captured in the PLM system developed. Involvement of end
users in the design process is important, and design should be
iterative, with ongoing dialogue between designers and front-
line clinical professionals. Excellent communication and good
documentation would be essential for large scale deployment
of adaptive manufacturing for future emergency scenarios. The
use of PLM would ensure that the workflows are well-suited to
the ultimate objective, whether that is the manufacture of many
items, custom production of a single part, or simply generating
data to inform important decisions.
The project indicated that reverse engineering is not
necessarily suitable for all components, although it did confirm
that complex shapes such as the manifold or leak port could
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FIGURE 13 | PLM implementation into Aras Innovator – a platform for the coordination of bespoke medical equipment: (A) the PLM stages in Aras, each stage
requires a number of tasks to be accomplished and documents to be produced; (B) each new job begins with the start of a new PLM life cycle; (C) roles are assigned
to contacts; (D) the software advances through the life stages informing people of the tasks they have to accomplish automatically, either on the online platform or by
email.
be reproduced to some extent by reverse engineering and rapid
prototyping. There were numerous challenges, both technical
and otherwise, some of which remain unsolved. Some features
were difficult to capture and reproduce, examples being the O-
ring of the manifold and the slots in the leak port. Sometimes
the reconstruction of the geometry can be facilitated by the
removal of unnecessary features or the simplifying assumption
of symmetry. It is not always necessary to have a full CADmodel,
depending on the application.
Function is often more important than form. This is reflected
in the PLM system, which encourages the provision of detailed
design specifications in the early stages of the project. Attempting
a slavish reproduction of the overall shape of the original
part is not guaranteed to deliver satisfactory performance. A
combination of forward and reverse engineering may be more
powerful, as this would ensure that only themost essential aspects
of the shape would be reproduced, and the function would
be emphasised.
Where it is necessary to create a model with accurate
dimensions, this would be greatly facilitated if the scanner
were to be calibrated prior to use with a certified standard.
This would eliminate the need to scale the models using
manual measurements, which is a potential source of error.
However, even if the model is accurately scaled, it is difficult to
establish the permitted tolerance of machining without access
to full technical documentation or a large number of example
parts. In some cases, dimensions and tolerances are specified
in ISO standards, such as conical connectors for anaesthetic
and respiratory equipment (ISO 5356-1:2015), and this could
potentially eliminate the need to take measurements.
Another difficulty encountered was the scanning of
transparent objects. Chalk spray can enable transparent
objects to be scanned but CT scanning is often necessary in such
cases, as shown here. For the purposes of this paper, a medical
grade CT scanner was used due to its ready accessibility, but
the resolution of this system was limited. However, in many
cases, optical/CT scanning is unnecessary and conventional
measurements using Vernier callipers etc are sufficient.
As already noted, attempting to reverse engineer any part,
medical or otherwise, presents potential legal issues due to the
possibility of intellectual property infringement, with reference
to patents or design rights. In some jurisdictions it is possible
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FIGURE 14 | Critical evaluation of components. Table shows user testing, evaluation and conclusion, with embedded photographs illustrating areas for improvement
for each prototype examined. (a) 22mm connector fitted onto shaft of first version of reverse engineered manifold cover (b) original manifold cover, with critical
dimension shown (c) first version of reverse engineered manifold cover, with discrepancy shown (d) source of leak in version 2 of the reverse engineered manifold
cover (e) unsatisfactory edging on syringe pump lock box.
for legislation to be activated to enable production of proprietary
parts by other manufacturers during emergencies but this does
not always happen. The situation is often far from clear and in
some cases, it is very challenging to find out whether there is a
risk of infringement. For example, in the case of the plasticware
for testing, the method had been protected by a patent but this
had expired by the time of the COVID emergency. Reverse
engineering components with expired patents can be valuable,
as such products have been thoroughly tested and are highly
familiar to users. However, even in the absence of a current
patent there may still be some form of intellectual property
protection for the components, perhaps in the form of design
rights, and without in-depth legal advice it would be difficult to
know whether it was safe to proceed. Some of the technical and
legal issues could potentially be overcome by a strong partnership
with the original manufacturer.
The other major legal issue is compliance with medical device
regulations, the landscape for which is complex and changing.
Before production of any item for real world use, it is necessary to
confirmwhether it is or is not a medical device, which regulations
apply and what must be done to ensure compliance. To the best
of our knowledge, and as confirmed by informal dialogue with
the UK regulatory body (MHRA), the syringe pump lockbox does
not meet the definition of a “medical device” or “accessory” (62).
MHRA guidance notes that “Modifying existing devices or
using them for purposes not intended by the manufacturer
(off-label use) has safety implications” and “It is essential that
modifications outside of the manufacturer’s intended use are
only considered as part of a fully documented risk management
process within the healthcare organisation’s risk management
policy and procedures” (63). If due process is observed, it is
possible for hospitals to use alternatives for some components.
For instance, a viral filter with a cap removed can be used under
some circumstances instead of a leak port in a CPAP (Continuous
Positive Airway Pressure) NIV system (64, 65).
Medical devices and equipment that are manufactured “in-
house” and are to be used clinically, are expected to follow best
practice guidance (66). This includes manufacturing as part of
an appropriate Quality Management System, such as one that
meets the requirements of “BS EN ISO 13485:2016, Medical
devices. Quality management systems. Requirements for regulatory
purposes.” Specialist companies, including consultancies, are
very well-equipped to handle the intensive process of medical
device development. However, the pandemic has demonstrated
that emergency situations may require broader networks of
manufacturers and more agile supply chains, which can be
rapidly expanded and contracted to meet demand. Agile
regulations are required so that adaptive manufacturing can be
exploited to the full, and some countries did indeed modify or
relax regulations during the COVID-19 emergency (67).
The issues around “In-house” manufacturing are complex
when a distributed manufacturing model is considered. In the
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UK, Medical Devices manufactured by a Health Institution and
used by patients within that institution are not considered to have
been placed on the market and the Medical Device Regulations
do not apply. However, the devices cannot be transferred to
another legal entity as this is viewed as placing the devices on the
market and CE/UKCA marking is required (68).
In a 2017 draft consultation document, the MHRA provided
more detail about what activities are considered “manufacturing,”
noting “Items that are used to replace a part or component of a
device and that significantly change the performance or safety
characteristics or the intended purpose of the device shall be
considered to be modification” (69). Institutions that modify a
medical device [this includes “use of sample types, accessories or
components or combining devices not specified by the (original)
manufacturer” (69)] may assume the liability as the manufacturer
of the medical device.
In order for replacement parts to be manufactured using
a distributed manufacturing model and for this process to be
considered as “in-house” manufacturing, it should be made clear
that the Health Institution is the legal entity responsible for such
manufacturing even when the part is created by a university or
commercial partner.
Members of the Physical Healthcare Sciences already produce
numerous custom or patient specific devices, including items
for surgery, improving patients experience and lifestyle and
in training of clinical staff. As clinical services wish to adopt
personalised healthcare within the patient pathway, there will
be increased demand to design and manufacture a wider range
of in-house devices and solutions, using methods such as those
presented in this work, to develop solutions and associated design
and testing documentation to comply with incoming medical
device regulations. In-house production of rapidly prototyped
components would not only support the precision medicine
agenda, and ensure the supply of essential consumables in a time
of emergency, but would help to enable older apparatus to be
kept in operation after the Original Equipment Manufacturer
has ceased support. Production runs would be small but rapid
turnarounds would be needed. By using a PLM system such as
that presented here, which allows the workflow to be adapted to
the project, operations could be managed effectively and well-
documented. As has been shown, adaptive manufacturing has
remarkable potential for supporting an emergency response but
also for routine production of essential items, in healthcare and
other domains.
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